Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab

Objective: To evaluate humoral and T-cell cellular-mediated immune response after three doses of SARS-CoV-2 mRNA vaccines in patients with systemic lupus erythematosus (SLE) under Belimumab. Patients and methods: 12 patients on Belimumab and 13 age-matched healthy volunteers were recruited. Patients...

Full description

Bibliographic Details
Main Authors: Luca Quartuccio, Ginevra De Marchi, Rossana Domenis, Nicola Cabas, Silvia Guella, Antonella Paradiso, Cinzia Fabro, Antonio Paolo Beltrami, Salvatore De Vita, Francesco Curcio
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Journal of Clinical Medicine
Subjects:
lupus
belimumab
vaccine
coronavirus
COVID-19
immunity
Online Access:https://www.mdpi.com/2077-0383/12/3/1083

Internet

https://www.mdpi.com/2077-0383/12/3/1083

Similar Items